Bhavik Shah

4.1k total citations
15 papers, 1.5k citations indexed

About

Bhavik Shah is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Genetics. According to data from OpenAlex, Bhavik Shah has authored 15 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cognitive Neuroscience, 9 papers in Psychiatry and Mental health and 6 papers in Genetics. Recurrent topics in Bhavik Shah's work include Autism Spectrum Disorder Research (10 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Genetics and Neurodevelopmental Disorders (4 papers). Bhavik Shah is often cited by papers focused on Autism Spectrum Disorder Research (10 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Genetics and Neurodevelopmental Disorders (4 papers). Bhavik Shah collaborates with scholars based in United States and Netherlands. Bhavik Shah's co-authors include Lawrence David Scahill, Christopher J. McDougle, Elisabeth M. Dykens, Michael G. Aman, Benedetto Vitiello, Elaine Tierney, James T. McCracken, David J. Posey, L. Eugene Arnold and Louise Ritz and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Bhavik Shah

15 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bhavik Shah United States	15	999	901	443	346	235	15	1.5k
Jaswinder K. Ghuman United States	23	1.2k 1.2×	1.3k 1.4×	717 1.6×	308 0.9×	167 0.7×	34	1.9k
Valentina Postorino Italy	21	1.0k 1.0×	743 0.8×	846 1.9×	197 0.6×	92 0.4×	29	1.4k
Marcelo Schmitz Brazil	19	505 0.5×	1.2k 1.3×	387 0.9×	104 0.3×	115 0.5×	35	1.5k
Robert Doyle United States	26	855 0.9×	1.5k 1.7×	483 1.1×	102 0.3×	129 0.5×	43	2.0k
Arthur M. Small United States	16	737 0.7×	942 1.0×	562 1.3×	172 0.5×	126 0.5×	17	1.3k
Beate Oerbeck Norway	22	452 0.5×	489 0.5×	511 1.2×	85 0.2×	255 1.1×	46	1.2k
Marco Angriman Italy	18	337 0.3×	687 0.8×	232 0.5×	200 0.6×	229 1.0×	32	1.3k
Marie–Christine Mouren France	14	383 0.4×	447 0.5×	316 0.7×	113 0.3×	78 0.3×	28	1.0k
M Campbell United States	16	535 0.5×	700 0.8×	376 0.8×	153 0.4×	124 0.5×	29	994
Robert Sovner United States	17	448 0.4×	562 0.6×	411 0.9×	199 0.6×	68 0.3×	31	1.1k

Countries citing papers authored by Bhavik Shah

Since Specialization

Citations

This map shows the geographic impact of Bhavik Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhavik Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhavik Shah more than expected).

Fields of papers citing papers by Bhavik Shah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhavik Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhavik Shah. The network helps show where Bhavik Shah may publish in the future.

Co-authorship network of co-authors of Bhavik Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Bhavik Shah. A scholar is included among the top collaborators of Bhavik Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhavik Shah. Bhavik Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Aman, Michael G., Mallikarjuna Rettiganti, Haikady N. Nagaraja, et al.. (2015). Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 25(6). 482–493. 55 indexed citations

Scahill, Lawrence David, James T. McCracken, Bryan H. King, et al.. (2015). Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder. American Journal of Psychiatry. 172(12). 1197–1206. 119 indexed citations

Dykens, Elisabeth M., et al.. (2015). Psychiatric disorders in adolescents and young adults with Down syndrome and other intellectual disabilities. Journal of Neurodevelopmental Disorders. 7(1). 9–9. 49 indexed citations

Nikolov, Roumen, Karen Bearss, Craig A. Erickson, et al.. (2008). Gastrointestinal Symptoms in a Sample of Children with Pervasive Developmental Disorders. Journal of Autism and Developmental Disorders. 39(3). 405–413. 163 indexed citations

Posey, David J., Michael G. Aman, James T. McCracken, et al.. (2007). Positive Effects of Methylphenidate on Inattention and Hyperactivity in Pervasive Developmental Disorders: An Analysis of Secondary Measures. Biological Psychiatry. 61(4). 538–544. 83 indexed citations

Scahill, Lawrence David, Michael G. Aman, Christopher J. McDougle, et al.. (2006). AProspective Open Trial of Guanfacine in Children with Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 16(5). 589–598. 83 indexed citations

Tierney, Elaine, Michael G. Aman, L. Eugene Arnold, et al.. (2006). Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study. Psychopharmacology. 191(1). 149–157. 16 indexed citations

Anderson, George M., Lawrence David Scahill, James T. McCracken, et al.. (2006). Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism. Biological Psychiatry. 61(4). 545–550. 124 indexed citations

Aman, Michael G., L. Eugene Arnold, Christopher J. McDougle, et al.. (2005). Acute and Long-Term Safety and Tolerability of Risperidone in Children with Autism. Journal of Child and Adolescent Psychopharmacology. 15(6). 869–884. 113 indexed citations

10.

McDougle, Christopher J., Lawrence David Scahill, Michael G. Aman, et al.. (2005). Risperidone for the Core Symptom Domains of Autism: Results From the Study by the Autism Network of the Research Units on Pediatric Psychopharmacology. American Journal of Psychiatry. 162(6). 1142–1148. 291 indexed citations

11.

Dykens, Elisabeth M. & Bhavik Shah. (2003). Psychiatric Disorders in Prader-Willi Syndrome. CNS Drugs. 17(3). 167–178. 103 indexed citations

12.

Arnold, L. Eugene, Benedetto Vitiello, Christopher J. McDougle, et al.. (2003). Parent-Defined Target Symptoms Respond to Risperidone in RUPP Autism Study: Customer Approach to Clinical Trials. Journal of the American Academy of Child & Adolescent Psychiatry. 42(12). 1443–1450. 149 indexed citations

13.

O’Connor, Mary J., et al.. (2002). Psychiatric Illness in a Clinical Sample of Children with Prenatal Alcohol Exposure. The American Journal of Drug and Alcohol Abuse. 28(4). 743–754. 127 indexed citations

14.

King, Bryan H., Matthew W. State, Bhavik Shah, Pablo Davanzo, & Elisabeth M. Dykens. (1997). Mental Retardation: A Review of the Past 10 Years. Part I. Journal of the American Academy of Child & Adolescent Psychiatry. 36(12). 1656–1663. 32 indexed citations

15.

Dykens, Elisabeth M., Robert M. Hodapp, Jennifer A. Halliday, et al.. (1997). Eating Themselves to Death: Have “Personal Rights” Gone Too Far in Treating People With Prader-Willi Syndrome?. Mental Retardation. 35(4). 312–314. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact